Skip to main content
Top
Published in: Endocrine 1/2017

01-01-2017 | Clinical Management of Endocrine Diseases

SIADH: differential diagnosis and clinical management

Authors: Alessandro Peri, Christian Grohé, Rossana Berardi, Isabelle Runkle

Published in: Endocrine | Issue 1/2017

Login to get access

Abstract

Despite the widespread prevalence of hyponatremia and its deleterious effects on patients, it is often overlooked and consequently undertreated. This set of four cases provides practical advice on how to identify, diagnose, and treat patients with syndrome of inappropriate antidiuretic hormone (SIADH). The first steps that a physician should take when diagnosing a patient with hyponatremia are to assess the severity of neurological symptoms, and check the patient’s volemic status in order to determine whether emergency treatment with hypertonic saline is indicated. Laboratory tests are necessary for the diagnosis of SIADH, but, in severe, symptomatic cases of hyponatremia, patients need treatment before the results of laboratory tests can be obtained. In this series, Case 1 demonstrates how awareness of hyponatremia led to early diagnosis and treatment. Case 2 demonstrates how multiple causes of hyponatremia can be diagnosed and managed sequentially. Case 3 illustrates how a patient with severe symptoms should be treated while waiting for laboratory test results to confirm diagnosis. Case 4 examines how the priorities of a patient should inform the management of their chronic SIADH, using palliative care of a patient with small-cell lung cancer as an example. There are several factors that clinicians should consider when making treatment decisions, including signs and symptoms, risks and benefits of different treatments, psychosocial factors, and the patient’s wishes. All the available treatment options have a place in the management of patients with SIADH, and a physician should individualize decisions based on a patient’s needs and priorities.
Literature
1.
go back to reference A. Upadhyay, B.L. Jaber, N.E. Madias, Incidence and prevalence of hyponatremia. Am. J. Med. 119, 30–35 (2006)CrossRef A. Upadhyay, B.L. Jaber, N.E. Madias, Incidence and prevalence of hyponatremia. Am. J. Med. 119, 30–35 (2006)CrossRef
3.
go back to reference A. Peri, N. Pirozzi, G. Parenti, F. Festuccia, P. Menè, Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone. J. Endocrinol. Invest. 33, 671–682 (2010)CrossRefPubMed A. Peri, N. Pirozzi, G. Parenti, F. Festuccia, P. Menè, Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone. J. Endocrinol. Invest. 33, 671–682 (2010)CrossRefPubMed
4.
go back to reference W. Fenske, S.K. Maier, A. Blechschmidt, B. Allolio, S. Störk, Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am. J. Med. 123, 652–657 (2010)CrossRefPubMed W. Fenske, S.K. Maier, A. Blechschmidt, B. Allolio, S. Störk, Utility and limitations of the traditional diagnostic approach to hyponatremia: a diagnostic study. Am. J. Med. 123, 652–657 (2010)CrossRefPubMed
5.
go back to reference G. Corona, C. Giuliani, G. Parenti, D. Norello, J.G. Verbalis, G. Forti et al., Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8, e80451 (2013)CrossRefPubMedPubMedCentral G. Corona, C. Giuliani, G. Parenti, D. Norello, J.G. Verbalis, G. Forti et al., Moderate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysis. PLoS One 8, e80451 (2013)CrossRefPubMedPubMedCentral
6.
go back to reference L. Holland-Bill, C.F. Christiansen, U. Heide-Jørgensen, S.P. Ulrichsen, T. Ring, J.O. Jørgensen et al., Hyponatremia and mortality risk: a Danish cohort study of 279,508 acutely hospitalized patients. Eur. J. Endocrinol. 173, 71–81 (2015)CrossRefPubMed L. Holland-Bill, C.F. Christiansen, U. Heide-Jørgensen, S.P. Ulrichsen, T. Ring, J.O. Jørgensen et al., Hyponatremia and mortality risk: a Danish cohort study of 279,508 acutely hospitalized patients. Eur. J. Endocrinol. 173, 71–81 (2015)CrossRefPubMed
7.
go back to reference R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, N.E. Madias, Impact of hospital-associated hyponatremia on selected outcomes. Arch. Intern. Med. 170, 294–302 (2010)CrossRefPubMed R. Wald, B.L. Jaber, L.L. Price, A. Upadhyay, N.E. Madias, Impact of hospital-associated hyponatremia on selected outcomes. Arch. Intern. Med. 170, 294–302 (2010)CrossRefPubMed
8.
go back to reference K.M. Chow, B.C. Kwan, C.C. Szeto, Clinical studies of thiazide-induced hyponatremia. J. Natl Med. Assoc. 96, 1305–1308 (2004)PubMedPubMedCentral K.M. Chow, B.C. Kwan, C.C. Szeto, Clinical studies of thiazide-induced hyponatremia. J. Natl Med. Assoc. 96, 1305–1308 (2004)PubMedPubMedCentral
9.
go back to reference G. Gill, B. Huda, A. Boyd, K. Skagen, D. Wile, I. Watson, C. van Heyningen, Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin. Endocrinol. (Oxf.) 65, 246–249 (2006)CrossRef G. Gill, B. Huda, A. Boyd, K. Skagen, D. Wile, I. Watson, C. van Heyningen, Characteristics and mortality of severe hyponatraemia—a hospital-based study. Clin. Endocrinol. (Oxf.) 65, 246–249 (2006)CrossRef
11.
go back to reference E.J. Hoorn, J. Lindemans, R. Zietse, Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transpl. 21, 70–76 (2006)CrossRef E.J. Hoorn, J. Lindemans, R. Zietse, Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol. Dial. Transpl. 21, 70–76 (2006)CrossRef
12.
go back to reference E.J. Hoorn, P.M. Bouloux, V. Burst, Perspectives on the management of hyponatraemia secondary to SIADH across Europe. Best Pract. Res. Clin. Endocrinol. Metab. 26(Suppl 1), S27–S32 (2012)CrossRefPubMed E.J. Hoorn, P.M. Bouloux, V. Burst, Perspectives on the management of hyponatraemia secondary to SIADH across Europe. Best Pract. Res. Clin. Endocrinol. Metab. 26(Suppl 1), S27–S32 (2012)CrossRefPubMed
13.
go back to reference M.S. Huda, A. Boyd, K. Skagen, D. Wile, C. van Heyningen, I. Watson et al., Investigation and management of severe hyponatraemia in a hospital setting. Postgrad. Med. J. 82, 216–219 (2006)CrossRefPubMedPubMedCentral M.S. Huda, A. Boyd, K. Skagen, D. Wile, C. van Heyningen, I. Watson et al., Investigation and management of severe hyponatraemia in a hospital setting. Postgrad. Med. J. 82, 216–219 (2006)CrossRefPubMedPubMedCentral
14.
go back to reference A. Greenberg, J.G. Verbalis, A.N. Amin, V.R. Burst, J.A. Chiodo 3rd, J.R. Chiong et al., Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 88(1), 167–177 (2015)CrossRefPubMedPubMedCentral A. Greenberg, J.G. Verbalis, A.N. Amin, V.R. Burst, J.A. Chiodo 3rd, J.R. Chiong et al., Current treatment practice and outcomes. Report of the hyponatremia registry. Kidney Int. 88(1), 167–177 (2015)CrossRefPubMedPubMedCentral
15.
go back to reference G. Corona, C. Giuliani, J.G. Verbalis, G. Forti, M. Maggi, A. Peri, Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 10, e0124105 (2015)CrossRefPubMedPubMedCentral G. Corona, C. Giuliani, J.G. Verbalis, G. Forti, M. Maggi, A. Peri, Hyponatremia improvement is associated with a reduced risk of mortality: evidence from a meta-analysis. PLoS One 10, e0124105 (2015)CrossRefPubMedPubMedCentral
17.
go back to reference C. Giuliani, M. Cangioli, P. Beck-Peccoz, M. Faustini-Fustini, E. Fiaccadori, A. Peri, Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey. J. Endocrinol. Invest. 36, 693–698 (2013)PubMed C. Giuliani, M. Cangioli, P. Beck-Peccoz, M. Faustini-Fustini, E. Fiaccadori, A. Peri, Awareness and management of hyponatraemia: the Italian Hyponatraemia Survey. J. Endocrinol. Invest. 36, 693–698 (2013)PubMed
18.
go back to reference J.G. Verbalis, Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol. Nutr. 57(Suppl 2), 30–40 (2010)CrossRefPubMed J.G. Verbalis, Managing hyponatremia in patients with syndrome of inappropriate antidiuretic hormone secretion. Endocrinol. Nutr. 57(Suppl 2), 30–40 (2010)CrossRefPubMed
19.
go back to reference J.G. Verbalis, A. Grossman, C. Höybye, I. Runkle, Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia. Curr. Med. Res. Opin. 30, 1201–1207 (2014)CrossRefPubMed J.G. Verbalis, A. Grossman, C. Höybye, I. Runkle, Review and analysis of differing regulatory indications and expert panel guidelines for the treatment of hyponatremia. Curr. Med. Res. Opin. 30, 1201–1207 (2014)CrossRefPubMed
20.
go back to reference J.G. Verbalis, S.R. Goldsmith, A. Greenberg, C. Korzelius, R.W. Schrier, R.H. Sterns et al., Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126(10 Suppl 1), S1–S42 (2013)CrossRefPubMed J.G. Verbalis, S.R. Goldsmith, A. Greenberg, C. Korzelius, R.W. Schrier, R.H. Sterns et al., Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations. Am. J. Med. 126(10 Suppl 1), S1–S42 (2013)CrossRefPubMed
21.
go back to reference H. Furst, K.R. Hallows, J. Post, S. Chen, W. Kotzker, S. Goldfarb et al., The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am. J. Med. Sci. 319, 240–244 (2000)CrossRefPubMed H. Furst, K.R. Hallows, J. Post, S. Chen, W. Kotzker, S. Goldfarb et al., The urine/plasma electrolyte ratio: a predictive guide to water restriction. Am. J. Med. Sci. 319, 240–244 (2000)CrossRefPubMed
22.
23.
go back to reference R.F. Reeder, R.E. Harbaugh, Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J. Neurosurg. 70, 201–206 (1989)CrossRefPubMed R.F. Reeder, R.E. Harbaugh, Administration of intravenous urea and normal saline for the treatment of hyponatremia in neurosurgical patients. J. Neurosurg. 70, 201–206 (1989)CrossRefPubMed
24.
go back to reference G. Decaux, J. Unger, S. Brimioulle, J. Mockel, Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247, 471–474 (1982)CrossRefPubMed G. Decaux, J. Unger, S. Brimioulle, J. Mockel, Hyponatremia in the syndrome of inappropriate secretion of antidiuretic hormone. Rapid correction with urea, sodium chloride, and water restriction therapy. JAMA 247, 471–474 (1982)CrossRefPubMed
25.
go back to reference J.E. Morley, Dehydration, hypernatremia, and hyponatremia. Clin. Geriatr. Med. 31, 389–399 (2015)CrossRefPubMed J.E. Morley, Dehydration, hypernatremia, and hyponatremia. Clin. Geriatr. Med. 31, 389–399 (2015)CrossRefPubMed
26.
go back to reference W. Musch, G. Decaux, Treating the syndrome of inappropriate ADH secretion with isotonic saline. Q. J. Med. 91, 749–753 (1998)CrossRef W. Musch, G. Decaux, Treating the syndrome of inappropriate ADH secretion with isotonic saline. Q. J. Med. 91, 749–753 (1998)CrossRef
27.
go back to reference T. Berl, F. Quittnat-Pelletier, J.G. Verbalis, R.W. Schrier, D.G. Bichet, J. Ouyang et al., Oral tolvaptan is safe and effective in chronic hyponatremia. J. Am. Soc. Nephrol. 21, 705–712 (2010)CrossRefPubMedPubMedCentral T. Berl, F. Quittnat-Pelletier, J.G. Verbalis, R.W. Schrier, D.G. Bichet, J. Ouyang et al., Oral tolvaptan is safe and effective in chronic hyponatremia. J. Am. Soc. Nephrol. 21, 705–712 (2010)CrossRefPubMedPubMedCentral
28.
go back to reference R.W. Schrier, P. Gross, M. Gheorghiade, T. Berl, J.G. Verbalis, F.S. Czerwiec et al., Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099–2112 (2006)CrossRefPubMed R.W. Schrier, P. Gross, M. Gheorghiade, T. Berl, J.G. Verbalis, F.S. Czerwiec et al., Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N. Engl. J. Med. 355, 2099–2112 (2006)CrossRefPubMed
29.
go back to reference C. Grohé, R. Berardi, V. Burst, Hyponatraemia-SIADH in lung cancer diagnostic and treatment algorithms. Crit. Rev. Oncol. Hematol. 96(1), 1–8 (2015)CrossRefPubMed C. Grohé, R. Berardi, V. Burst, Hyponatraemia-SIADH in lung cancer diagnostic and treatment algorithms. Crit. Rev. Oncol. Hematol. 96(1), 1–8 (2015)CrossRefPubMed
Metadata
Title
SIADH: differential diagnosis and clinical management
Authors
Alessandro Peri
Christian Grohé
Rossana Berardi
Isabelle Runkle
Publication date
01-01-2017
Publisher
Springer US
Published in
Endocrine / Issue 1/2017
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-0936-3

Other articles of this Issue 1/2017

Endocrine 1/2017 Go to the issue